Kemper (KMPR) Q2 2026 Earnings Call Transcript

Kemper reported a Q2 2026 net loss of $464.8M (loss of $7.90/share), driven primarily by a $460M non-cash goodwill impairment after a sustained 50% YoY share price decline, with adjusted net operating income of $26.3M (+$0.45/share) still improving sequentially. Underlying profitability improved (specialty auto combined ratio improved to 105.2%, +130 bps sequentially; commercial auto underlying combined ratio at 93.7%), but California personal auto policy counts fell 10% sequentially to 928,000 and management reiterated a need for double-digit California rate increases (5.5% effective Q2, with 6.9% pending). Holding company liquidity remained $766M (including $350M revolver capacity), but debt to capital rose to 28.3%, alongside a $16.6M after-tax allowance on surplus notes related to the Kemper Reciprocal Exchange.

Analysis

The important signal is not the non-cash charge itself; it is that management has effectively admitted the specialty auto franchise is worth less than the market once assumed, which usually keeps the stock in a valuation penalty box until there is proof of durable underwriting improvement. In insurance, that matters because once reserve adequacy and fair value are questioned, investors demand a higher capital cushion and stop crediting “turnaround” narratives at full price.

The real operating risk is California bodily injury, where rate actions can help but rarely solve the problem quickly enough if frequency/severity keeps drifting up. That creates a second-order effect: as this book shrinks or slows, competitors with cleaner books and faster pricing discipline should absorb the better risk without needing to chase unprofitable share. PGR, TRV, and ALL are the cleaner beneficiaries; KMPR is forced into a slower-growth, higher-friction reset that can suppress multiples for several quarters.

Near term, the next two catalysts are the California filing outcome and any additional reserve development in commercial auto. If either disappoints, the market will start pricing a second impairment scenario well before GAAP catches up, and the equity can re-rate lower again even though liquidity looks adequate today. The contrarian case is that the impairment may be over-read as a cash event; but the better read is that the impairment is a lagging confirmation of a business that still has not earned its cost of capital.

What would falsify the bearish view: two straight quarters with no new adverse prior-year development, a visible step-down in California loss ratio, and evidence that personal auto can move meaningfully toward profitability without further policy attrition.

Key Decisions for Investors

• Short KMPR common on any post-earnings bounce; 1-3 month horizon. Thesis breaks if California rate approval plus Q3/Q4 reserve data show no further adverse development and personal auto combined ratio moves materially toward breakeven.
• Pair trade: long PGR or TRV / short KMPR for 3-6 months. This isolates underwriting-quality dispersion; the pair should work if the market continues to reward reserve credibility and penalize turnaround risk.
• Buy KMPR put spreads 3-6 months out rather than outright puts if positioning for another reserve or goodwill-related disappointment. Best entry is after a relief rally; cover the hedge if management delivers two consecutive clean reserve quarters.